Intrapulmonary deposition of IgG immune complexes into rat lung results in intense, acute inflammatory injury that is dependent on release from recruited neutrophils and tissue macrophages of toxic oxygen products and proteases. These processes disrupt the structural barriers established by the extracellular matrix [16, 17] , resulting in lung leak and hemorrhage. Intrapulmonary immune complexes are formed by intratracheal instillation of anti-bovine serum albumin (BSA) IgG followed by intravenous administration of BSA. The IgG immune complex model of lung injury is triggered by immune complexes that have been shown by immunostaining techniques to be deposited along alveolar walls of the lung [18] . Using this system, we tested the ability of an aptamer inhibitor of elastase to inhibit lung leak and neutrophil influx.
Results and discussion
Intrapulmonary deposition of IgG immune complexes into rat lung results in intense, acute inflammatory injury that is dependent on release from recruited neutrophils and tissue macrophages of toxic oxygen products and proteases. These processes disrupt the structural barriers established by the extracellular matrix [16, 17] , resulting in lung leak and hemorrhage. Intrapulmonary immune complexes are formed by intratracheal instillation of anti-bovine serum albumin (BSA) IgG followed by intravenous administration of BSA. The IgG immune complex model of lung injury is triggered by immune complexes that have been shown by immunostaining techniques to be deposited along alveolar walls of the lung [18] . Using this system, we tested the ability of an aptamer inhibitor of elastase to inhibit lung leak and neutrophil influx.
We recently described the isolation and characterization of highly potent and specific inhibitors of neutrophil elastase by the process of blended SELEX [15, 19] . For this, a small molecule (a valyl diphenylester phosphonate) was incorporated into a large library of nucleic acid sequences (>10 12 ). The library was iteratively selected for the sequences that best promote the covalent reaction of the small molecule with elastase, and these sequences were amplified to initiate another round of selection. The most active inhibitors isolated by this process show inactivation rate constants greater than 10 8 M -1 min -1 for human neutrophil elastase. This rate is 10 4 -fold greater than that for the phosphonate alone and is currently the fastest inactivation rate constant reported for any synthetic irreversible inhibitor of elastase. Structure of the elastase inhibitor NX21909. This is composed of two DNA oligonucleotides annealed together, shown folded into the proposed secondary structure. Upper-case letters in the top strand indicate nucleotides that were randomized in the starting library. The bottom strand is the 'splint' oligo, which was annealed to the fixedsequence regions of the library. The active-site serine of elastase attacks the phosphorus atom, displacing a phenyl group to form a stable serine-phosphonate ester.
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The compound used for the current studies, termed NX21909, is shown in Figure 1 . NX21909 inhibits rat elastase at concentrations greater than 20 nM, but no inhibition of cathepsin G activity was observed at inhibitor concentrations of up to 100 nM (Figure 2 ). Cathepsin G is a serine protease that is also released by activated neutrophils and is particularly abundant in rat neutrophils [16] . We calculate the second-order rate constants for inactivation as 1.1 ± 0.2 × 10 7 M -1 min -1 for rat elastase and less than 10 4 M -1 min -1 for rat cathepsin G. These inactivation rates mirror the specificity displayed for the human forms of elastase and cathepsin G and indicate that NX21909 can be used as a specific probe for the effects of elastase in disease models.
IgG immune complex-induced lung injury was quantified at 4 h by changes in vascular permeability as measured by leakage of [ 125 I]BSA into lung parenchyma (Figure 3a) . Permeability is a relatively sensitive indicator of lung injury, indicating a break in the lung vascular barrier, as this technique measures the extravascular presence of [ 125 I]albumin in lungs whose vasculature has been flushed to remove [ 125 I]albumin present in the blood. In the IgG model, mean permeability values (the ratio of radioactivity in the lungs to that in the blood) in the negative and positive controls were 0.15 ± 0.02 and 0.54 ± 0.03, respectively. When 5-40 nmol of the inhibitor complex were instilled intratracheally, the permeability index fell in proportion to the dose ( Figure  3c ). At the highest dose, permeability was reduced by 38% (permeability = 0.39, P = 0.003 compared to the positive control, Figure 3a ). The reduction of permeability caused by 40 nmol NX21909 compares to 54% reduction when 200 nmol recombinant human SLPI, a serine protease inhibitor, was used in the same model of lung injury [16] .
We controlled for nonspecific effects of oligonucleotide administration by testing each subunit of the inhibitor separately. The intratracheal administration of 20 nmol of the small splint oligo subunit of the inhibitor ( Figure 1 ) did not result in a significant reduction in the permeability index ( Figure 3a ). This subunit is able to inactivate human and rat neutrophil elastase in vitro, albeit slowly, with an inactivation rate constant 10 4 -10 5 M -1 min -1 (data not shown). Evidently, this level of activity is insufficient to have a biological effect at the concentrations used. Similarly, intratracheal administration of 20 nmol of the large 42-mer DNA subunit of the inhibitor also failed to significantly reduce permeability ( Figure 3a) . This subunit does not inhibit elastase in vitro.
The recruitment of neutrophils into rat lungs injured by IgG immune complex was quantified by measurement of lung myeloperoxidase (MPO) content. MPO reliably measures all neutrophils in the lung (exclusive of nonadherent neutrophils in blood that have been flushed from the lungs). Because of the neutrophil dependency of injury caused by intrapulmonary deposition of immune complexes, a close correlation exists between MPO content and extent of lung injury [18] .
Positive (0 nmol) controls showed a 91 (± 7)% increase in MPO content over negative (sham) controls (Figure 3b) . Intratracheal administration at time 0 of 5-40 nmol of the neutrophil elastase inhibitor resulted in a dose-dependent decrease in MPO content, with a reduction of 53 (± 10)% at the 40 nmol dose. This amount of inhibition of MPO content by NX21909 compares to 37% reduction with 200 nmol SLPI in the same model of lung injury [16] . The intratracheal administration of 20 nmol of the small splint oligo subunit of the inhibitor did not result in significant change in MPO content compared to the value in the positive controls, which were otherwise untreated (Figure 3b) . The large subunit also failed to cause significant reductions (<5%) in MPO content (Figure 3b ).
Regression analysis shows that the reductions in vascular leak and neutrophil influx are strongly dose dependent (Figure 3c) . The dependence appears to be linear in the range of doses used. This simple linearity is consistent with a model in which the biological effects of NX21909 are mediated by stoichiometric neutralization of elastase. An alternative hypothesis is that the inhibitor affects the ability of IgG to induce an inflammatory reaction. This sort of nonspecific interaction of the nucleic acids with IgG seems unlikely, however, as neither individual subunit is able to attenuate the immune response. Inhibition of rat neutrophil proteases. Assays for rat neutrophil elastase (rNE) and rat cathepsin G (rCG) are described in Materials and methods. k inact obs is the fraction of enzyme inactivated per minute. Theoretical curves are linear regression by least-squares analysis. The slopes of these curves are the observed second-order rate constants for inactivation. Neutrophil elastase appears to play an important part in numerous inflammatory conditions of the lung. The development of neutrophil elastase inhibitors for therapeutic purposes has been pursued using a variety of strategies, including the identification and production of endogenous inhibitors (such as α-1PI and SLPI) as well as synthesis of smaller organic molecules with anti-elastase activity. Serine proteases form a transient covalent complex between the enzyme active-site serine and the substrate peptide acyl carbon. Irreversible inhibitors, such as the valyl phosphonate moiety of NX21909 (Figure 1 ), form a stable version of this complex, thereby inactivating the enzyme [20] .
The aptamer inhibitor of elastase, NX21909, has similar inhibitory effects on vascular leak and neutrophil infiltration, strengthening the hypothesis that elastase has a key role in the development of lung injury in inflammatory diseases. Elastase inhibitors may reduce lung injury directly, by blocking the degradation of connective tissue by elastase or, more indirectly, by blocking the recruitment of neutrophils to the site of inflammation. The latter mechanism may be of particular importance in the development of therapeutic agents, as activated neutrophils release a number of degradative enzymes, oxygen metabolites and cytokines. These factors may cause more damage than could be attributed to the enzymatic activity of elastase alone.
Aptamers are a relatively new drug discovery platform that exploits the ability of nucleic acids to fold into stable structures that bind with high affinity and specificity to a variety of target molecules [21, 22] . In the case of anti-elastase aptamers, we have now shown that we can obtain extremely fast irreversible inhibitors of elastase [15, 19] and that these inhibitors are effective in ex vivo [19] and, in the present study, in vivo animal models of inflammatory disease. These results show continued progress in the development of aptamer technology, and in the development of anti-inflammatory therapeutics. 
Materials and methods
IgG immune complex-induced alveolitis
Male Long Evans (specific pathogen-free) rats (275-300 g, Charles River Breeding Laboratories, Inc.) were used for all studies. Intraperitoneal injections of ketamine (12.5-15 .0 mg per 100 g body weight) were used for sedation and anesthesia. Polyclonal rabbit IgG containing 2.5 mg anti-BSA (Organon Technique Corp.) was instilled [in a volume of 300 µl phosphate-buffered saline (PBS)] into the lungs via a tracheal cannula. BSA (10 mg) was injected intravenously (i.v.) immediately thereafter (in a volume of 0.5 ml PBS). The rats were killed 4 h later.
Elastase inhibitor
The elastase inhibitor NX21909 is a 42-nucleotide derivative of the 71-nucleotide isolate ED38, described in [15] . The structure of the inhibitor is shown schematically in Figure 1 . DNA for the larger subunit was synthesized by Operon, and purified by reverse-phase HPLC. The smaller subunit, containing the valyl phosphonate, was synthesized and purified as described [15] . The intact inhibitor was assembled by annealing the two constituent oligonucleotides in a 1:1 molar ratio at 65°C for 2 min, then cooling to 37°C. Inhibition of rat neutrophil elastase and cathepsin G (partially purified, Athens Research) was measured by a colorimetric assay, and analyzed by a progress curve method [19] . The substrate for elastase was N-methoxysuccinyl-Ala-Ala-Pro-Val-p-nitroanilide, and the cathepsin G substrate was N-methoxysuccinyl-Ala-Ala-Pro-Phe-p-nitroanilide (Calbiochem), both at 0.5 mM.
Intrapulmonary use of the neutrophil elastase inhibitor
The elastase inhibitor was instilled intratracheally together with the polyclonal rabbit anti-BSA IgG. The neutrophil elastase inhibitor was used in total amounts ranging from 5-40 nmol. Both the elastase inhibitor and polyclonal rabbit IgG were dissolved in a volume of 150µl PBS, pH 7.4. 
Measurement of lung permeability
Measurement of neutrophil accumulation by myeloperoxidase quantification
Whole lungs obtained at the time of killing were flushed via the pulmonary artery with 10 ml PBS, dissected, and frozen immediately in liquid nitrogen. After mechanical homogenization, MPO content was quantitated using a protocol described in [23] .
Statistical analysis
All values were expressed as mean ± 1.0 s.e.m. Data sets were examined with one-and two-way ANOVA and individual group means were then compared by Student's t-test.
